Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
158 results about "Hyperhidrosis" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A condition characterized by excessive sweating.
Methods for treating idiopathic hyperhidrosis and associated conditions
InactiveUS20040192754A1Reduced activityAlleviate and treat symptomBiocideAnimal repellantsAllosteric modulatorMianserin Hydrochloride
The subject invention provides methods for treating symptoms and / or conditions associated with idiopathic hyperhidrosis by using compounds that decrease the activity of serotonin 5-HT2C receptors. Compounds that can ameliorate symptoms of idiopathic hyperhidrosis and associated conditions include 5-HT2C receptor antagonists (i.e., ketanserin, ritanserin, mianserin, mesulergine, cyproheptadine, fluoxetine, mirtazapine, olanzapine, and ziprasidone) as well as 5-HT2C receptor modulators (i.e., inverse agonists, partial agonists, and allosteric modulators).
Owner:SHAPIRA NATHAN ANDREW +2
Topically applied clostridium botulinum toxin compositions and treatment methods
InactiveUS20030113349A1Efficient use ofBacterial antigen ingredientsPeptide/protein ingredientsChromhidrosisSeborrheic dermatitis
Hyperactive glandular conditions are treated using topically formulated botulinum toxin compositions. In the preferred embodiment of the invention, topical botulinum preparations are applied directly to the skin by a patient as needed to suppress his or her hyperhidrosis, bromhidrosis, chromhidrosis, nevus sudoriferous, acne, seborrhiec dermatitis or other glandular condition. In other embodiments, topical botulinum toxins are applied with the aid of mechanical, electrical, and / or chemical transdermal delivery enhancers.
Owner:COLEMAN WILLIAM P III
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
The present invention describes compositions and methods for treating, preventing and improving the appearance of skin, particularly, treating, preventing, ameliorating, reducing and / or eliminating fine lines and / or wrinkles of skin, wherein the compositions include limonoid constituents which inhibit acetylcholine release at neuromuscular junctions of skeletal muscle so as to relax the muscles involved with wrinkling, folding and creasing of skin, e.g., facial movement and expression. The limonoids preferably include the plant alkaloids toosendanin and azadirachtin. The compositions, which also are used to treat hyperhidrosis, are preferably applied to the skin, or are delivered by directed means to a site in need thereof.
Owner:AVON PROD INC
Handpiece and methods for performing subcutaneous surgery
ActiveUS20140257272A1Increase kinetic energyReduce air pressureCosmetic implantsDiagnosticsSubcutaneous tissueAtrophic scars
Devices and methods for performing subcutaneous surgery in a minimally invasive manner are provided. The methods include application of reduced air pressure in a recessed area of a handpiece placed over a section of skin and drawing the section of skin and subcutaneous tissue into the recessed area. In a subsequent step a tool is inserted through a tool conduit in the handpiece and through the skin into the subcutaneous tissue, enabling the performance of the desired surgery. Common surgical procedures include dissection and ablation. The devices and methods can be directed at the treatment of skin conditions like atrophic scars, wrinkles, or other cosmetic issues, at treatments like or promoting wound healing or preventing hyperhidrosis, or can be used for creating space for various implants.
Owner:ULTHERA INC
Dermal delivery
InactiveUS20110212157A1Not induce unwanted clinical effects inside and/orEnsure adequate treatmentOrganic active ingredientsPowder deliveryHypopigmentationChromhidrosis
The present invention describes systems and methods for treating disorders and / or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and / or actinic keratosis. Methods generally involve administering nanoemulsions (e.g., nanoparticle compositions) comprising at least one therapeutic agent, such as botulinum toxin. In some embodiments, nanoemulsions are prepared, e.g., by high pressure microfluidization, and comprise a particle size distribution exclusively between 10 nm and 300 nm.
Owner:ANTERIOS INC
Dermal Delivery
InactiveUS20160213757A1Not induce unwanted clinical effects inside and/orEnsure adequate treatmentCosmetic preparationsPeptide/protein ingredientsHypopigmentationTherapeutic effect
The present invention describes systems and methods for treating disorders and / or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and / or actinic keratosis. Methods generally involve administering nanoemulsions (e.g., nanoparticle compositions) comprising at least one therapeutic agent, such as botulinum toxin. In some embodiments, nanoemulsions are prepared, e.g., by high pressure microfluidization, and comprise a particle size distribution exclusively between 10 nm and 300 nm.
Owner:ANTERIOS INC
Post-translational modifications and Clostridial neurotoxins
InactiveUS7223577B2Increase and decrease persistenceIncrease or decrease stabilityPeptide/protein ingredientsDepsipeptidesDiseasePost translational
The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
Owner:ALLERGAN INC
Modified clostridial neurotoxins with altered biological persistence
InactiveUS20020127247A1Increase and decrease persistenceIncrease or decrease stabilityNervous disorderPeptide/protein ingredientsDiseaseToxin
The present invention discloses modified neurotoxins with altered biological persistence. In one embodiment, the modified neurotoxins are derived from Clostridial botulinum toxins. Such modified neurotoxins may be employed in treating various conditions, including but not limited to muscular disorders, hyperhidrosis, and pain.
Owner:ALLERGAN INC
Topical glycopyrrolate formulations
ActiveUS20100276329A1Hyperhidrosis is substantially reducedEasy to carryBiocideCosmetic preparationsHydrophilic polymersHydrophobic polymer
Individually packaged topical formulations comprising about 0.25 to about 6% w / w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
Owner:ROSE U
Methods for the Treatment of Hyperhidrosis
The present invention relates in general to methods of treating sweating disorders and in particular to topical compositions for the treatment of hyperhidrosis. The methods of the present invention relate to the topical application of a composition comprising a therapeutically effective amount of oxybutynin, tolterodine or a substituted benzamide such as sulpiride.
Owner:ZINGER MENNI MENASHE
Topical glycopyrrolate formulations
ActiveUS8618160B2Easy to carryEasy to useCosmetic preparationsBiocideHydrophilic polymersHydrophobic polymer
Individually packaged topical formulations comprising about 0.25 to about 6% w / w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
Owner:ROSE U
Treatment of hyperhydrosis
A device for the treatment of hyperhydrosis by application of electric current to a treatment area of the skin is described. The device comprises: a) a garment comprising a first electrode adapted for contacting said treatment area; b) a second electrode adapted for contacting the treatment area or skin proximal to the treatment area; and c) a power delivery unit in electrical communication with said first and second electrodes. The power delivery unit provides a customized dose of electricity to the treatment area. In one embodiment, the garment is a glove.
Owner:JOHNSON & JOHNSON CONSUMER COPANIES
Transdermal compositions for Anti-cholinergic agents
InactiveUS20140037713A1Reduce morbidityAvoids undesirable odor and irritation effectsCosmetic preparationsOrganic active ingredientsOxybutyninSide effect
The present invention relates generally to compositions or formulations for transdermal or transmucosal administration of anti-cholinergic agents such as oxybutynin. The invention utilizes a novel delivery vehicle and is a substantially malodorous-free and irritation free transdermal formulation which is substantially live of long chain fatty alcohols, long-chain fatty acids, and long-chain fatty esters. A method is disclosed for treating a subject for hyperhidrosis with these formulations while reducing the incidences of peak concentrations of drug and undesirable side effects associated with oral anti-cholinergics.
Owner:ANTARES PHARMA IPL
Treatment of sweating and hyperhydrosis
InactiveUS20100082088A1Medical devicesPharmaceutical delivery mechanismHyperhidrosisElectric current
Devices, compositions and methods for the treatment of sweating and hyperhidrosis by application of electric current to a treatment area of the skin are described.
Owner:JOHNSON & JOHNSON INC (US)
Nanoparticle compositions
InactiveUS20120328702A1Limit deliveryEffective for topical administrationAntibacterial agentsPowder deliveryDiseaseWrinkle skin
The present invention describes novel nanoparticle compositions, and systems and methods utilizing them for treating disorders and / or conditions associated with the epidermal and / or dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, actinic keratosis, facial wrinkles, muscle contracture, and headache. Methods generally involve administering nanoparticle compositions to the skin.
Owner:ANTERIOS INC
Method of using radiation to treat cutaneous and sub-cutaneous conditions
InactiveUS20050010271A1Surgical instrument detailsLight therapyElectromagnetic radiationRadiation therapy
The present application discloses a method of applying electromagnetic radiation, preferably laser radiation, most preferably at differing wavelengths, to reduce the severity of the symptoms of lipodermatosclerosis, for example. The method can reduce the severity of cutaneous and subcutaneous induration, hyperpigmentation, hyperhidrosis or other fluid weeping from the skin, erythematous, leathery appearance and texture, and associated pain and discomfort. The most preferred method involves non-invasively painting the affected area with an Aura-i laser (532 nm wavelength, generally penetrating the skin at a depth of 3-4 mm) through sapphire cooling disks and with a Lyra-i laser (1064 nm wavelength, generally penetrating the skin more deeply, such as at a depth of 6-7 mm) also through sapphire cooling disks. The method preferably involves at least three such painting applications separated by two to six, and preferably four, week intervals.
Owner:MERCHANT ROBERT F
Compositions and methods for topical application and transdermal delivery of botulinum toxins
ActiveUS20070077259A1Reduce hypersecretionReduce sweatingCosmetic preparationsNervous disorderWrinkle skinPharmacology
Improved formulations for transdermal delivery of botulinum toxin are disclosed. The formulations include, for example, botulinum toxin non-covalently associated with a positively charged backbone having branching or efficiency groups. The formulations also include a partitioning agent, oligo-bridge, or polyanion bridge, and may optionally contain a viscosity modifying agent. The formulations are designed for topical application onto the skin of a patient and may be used to treat wrinkles, hyperhidrosis, and other health-related problems. Kits for administration are also described.
Owner:REVANCE THERAPEUTICS INC
Compositions and Methods for Topical Application and Transdermal Delivery of Botulinum Toxins
ActiveUS20090087457A1Reduce hypersecretionReduce sweatingCosmetic preparationsNervous disorderWrinkle skinPharmacology
Improved formulations for transdermal delivery of botulinum toxin are disclosed. The formulations include, for example, botulinum toxin non-covalently associated with a positively charged backbone having branching or efficiency groups. The formulations also include a partitioning agent, oligo-bridge, or polyanion bridge, and may optionally contain a viscosity modifying agent. The formulations are designed for topical application onto the skin of a patient and may be used to treat wrinkles, hyperhidrosis, and other health-related problems. Kits for administration are also described.
Owner:REVANCE THERAPEUTICS INC
Method of treating dyshidrosis(pompholyx) and related dry skin disorders
This invention discloses a method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and / or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (Juglans nigra), wormwood (Artemisia absinthium), tumeric rhizome (Curcuma longa), garlic (Allium sativum), two or more herbal antibacterial agents from the group consisting of chamomile (Matricaria Chamomile), licorice root (Glycyrrhiza glabra), St Johns wort (Hypericum perforatum), clove (Syzygium aromaticum), nutmeg (Myristica fragans), ginger (Zingiber officinale), frankincense (Boswellia carteri) and myrrh (Commiphora molmol), further combined with aloe vera and niacin.
Owner:MAZZIO ELIZABETH ANNE +1
Glycopyrrolate salts
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed.
Owner:JOURNEY MEDICAL CORP
Topically applied clostridium botulinum toxin compositions and treatment methods
InactiveUS20070116723A1Effective treatmentCosmetic preparationsBacterial antigen ingredientsNephrosisChromhidrosis
Hyperactive glandular conditions are treated using topically formulated botulinum toxin compositions. In the preferred embodiment of the invention, topical botulinum preparations are applied directly to the skin by a patient as needed to suppress his or her hyperhidrosis, bromhidrosis, chromhidrosis, nevus sudoriferous, acne, seborrhiec dermatitis or other glandular condition. In other embodiments, topical botulinum toxins are applied with the aid of mechanical, electrical, and / or chemical transdermal delivery enhancers.
Owner:COLEMAN III WILLIAM P
Treatment of hyperhydrosis
Owner:JOHNSON & JOHNSON CONSUMER COPANIES
Topical treatment for dyshidrosis (pompholyx) and dry skin disorders
A topical herbal formulation for preventing and / or treating dyshidrosis (pompholyx), non-responsive to topical steroids. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (Juglans Nigra), wormwood (Artemisia Absinthium), tumeric rhizome (Curcuma Longa), garlic (Allium sativum), chamomile (Matricaria Chamomile), licorice root (Glycyrrhiza Glabra), St Johns wort (Hypericum perforatum), aloe vera, niacin and herbal anti-bacterial agents.
Owner:MAZZIO ELIZABETH ANNE +1
Anti-sweat lotion
InactiveUS6319491B1Fast dryingSmooth skinCosmetic preparationsToilet preparationsAdditive ingredientHydrophobic silica
The present invention includes an anti-sweat lotion specifically designed for use by people suffering from hyperhidroses. In a preferred embodiment, the lotion of the present invention is a composition of the follow ingredients:a. denatured ethyl alcohol;b. hydrophobic silica;c. a monoethyl ester of the copolymer of methyl vinyl ether and maleic anhydride;d. iso-octahexacontane;e. octamethylcyclotetrasiloxane; and,f. hydroxypropylcelluose.In another preferred embodiment, the octamethylcyclotetrasiloxane is replaced by decamethylcyclopentasiloxane.
Owner:WHIPPLE MICHAEL B
Apparatus and cosmetic method for treating hyperhidrosis
A cosmetic method for treating a human body to reduce hyperhidrosis includes applying laser light energy to one or more portions of the human body in which the laser light energy is one or more of: about 450 nm, about 930 nm, about 970 nm and about 1060 nm. An apparatus for accomplishing this method includes a source of laser light energy and a controller for controlling the laser light source to apply laser light energy to target and disrupt sweat glands in the human body.
Owner:LUMENIS BE LTD
Compositions and methods for hyperhidrosis
The present disclosure relates, according to some embodiments, to compositions, systems, and methods for ameliorating, preventing, and / or treating (collectively “treating”) hyperhidrosis and / or excessive perspiration (collectively “hyperhidrosis”). For example, a method for treating hyperhidrosis may comprise administering (e.g., topically administering) a composition comprising an anticholinergic compound (e.g., an ipratropium compound) to a mammal. A composition (e.g., a topical composition) for treating hyperhidrosis may comprise an anticholinergic compound (e.g., an ipratropium compound) and a vehicle (e.g., a physiologically acceptable vehicle). In some embodiments, administering a composition comprising an anticholinergic compound may comprise contacting the subject with a medicated article comprising the composition.
Owner:KOLENG JOHN J +1
Sympathetic ganglion stimulation method for treatment of hyperhidrosis, Raynauds phenomenon, cerebral ischemia, asthma and hypertension
InactiveUS20130296977A1Symptoms improvedRelieve symptomsSpinal electrodesImplantable neurostimulatorsThermal energyCervical ganglia
Methods for treatment of hyperhidrosis, Raynaud's phenomenon, cerebral ischemia and asthma and hypertension by nerve stimulation are disclosed. In particular, the invention relates to the improvement of these conditions by stimulating at least one ganglion selected from the group consisting of T-1 through T-4 ganglia, cervical ganglia, renal nerve or combinations thereof with an implantable, wireless, battery-less and lead-less stimulator. Stimulations of the ganglion may be carried out with pulsed radiofrequency, thermal energy or optical irradiation.
Owner:CHIU HUNG WEI +2
Nanoparticle compositions
InactiveUS20150196490A1Effective for topical administrationLimit deliveryAntibacterial agentsPowder deliveryDiseaseCuticle
The present invention describes novel nanoparticle compositions, and systems and methods utilizing them for treating disorders and / or conditions associated with the epidermal and / or dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, actinic keratosis, facial wrinkles, muscle contracture, and headache. Methods generally involve administering nanoparticle compositions to the skin.
Owner:ANTERIOS INC
Chinese medicine preparation for curing fungi dermatosis and preparation method thereof
ActiveCN101181559AGood treatment effectRich sourcesHeavy metal active ingredientsOrganic active ingredientsSmelly feetIntensity scaling
The invention relates to a medicine for curing eumycete dermatosis and the preparation method. The medicine is made through the following steps: the japanese intensity scale maple, stemona root, selinum, broom cypress fruits, chaulmoogra, pseudolarix, sophora flavescens, sulfur, hernquecksilvea and amphor together are mixed according to weight proportion, then the mixture is immersed in acetic acid and filtered, and put in bottols finally. Through clinical verification and use, the invention has the functions of eliminating dampness and relieving itching, disinsection and curing eczema, which can be applied externally on the affected part, and mainly cures various eczemas, tetter, smelly feet and hyperhidrosis, with noticeable efficacy on various chronic eczemas. The invention has the advantages of simple manufacturing process, convenient use and noticeable efficacy.
Owner:广西云球生物科技有限公司
Nanoparticle compositions and components thereof
InactiveUS20120328525A1Good effectReduce frequencyAntibacterial agentsPowder deliveryChromhidrosisNanoparticle
The present invention describes systems and methods for treating disorders and / or conditions associated with the dermal level of the skin. Such disorders include acne, hyperhidrosis, bromhidrosis, chromhidrosis, rosacea, hair loss, dermal infection, and / or actinic keratosis, among others. Methods generally involve administering provided compositions to the skin.
Owner:ANTERIOS INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com